导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 22.59% | 177/1050 |
| 近一周 | -1.48% | 212/1104 |
| 近一月 | -7.74% | 893/1102 |
| 近一季 | -14.32% | 822/1092 |
| 近半年 | 17.81% | 168/1070 |
| 近一年 | 34.18% | 139/1018 |
| 近两年 | 185.86% | 66/926 |
| 近三年 | 147.57% | 59/834 |
| 成立以来 | 324.08% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.45% 779/1070 |
65.00% 159/1101 |
- - |
- - |
| 2025 | 64.95% 83/1065 |
4.46% 446/1014 |
3.98% 364/1038 |
55.21% 57/1050 |
-2.15% 565/1065 |
| 2024 | 29.12% 24/1011 |
1.30% 246/960 |
-0.33% 328/983 |
10.99% 550/991 |
15.22% 32/1011 |
| 2023 | -12.02% 398/952 |
7.71% 181/880 |
-0.62% 220/895 |
-11.33% 643/915 |
-7.30% 705/952 |
| 2022 | -36.37% 714/867 |
-22.32% 652/773 |
7.54% 370/806 |
-16.85% 675/845 |
-8.40% 750/867 |
| 2021 | 23.75% 128/740 |
-12.66% 537/580 |
32.83% 42/659 |
-3.41% 301/704 |
10.43% 76/740 |
| 2020 | 62.84% 177/554 |
2.02% 114/419 |
35.56% 66/466 |
5.29% 360/517 |
11.83% 300/554 |
| 2019 | 79.19% 12/410 |
28.89% 434/1146 |
-4.68% 685/1228 |
23.71% 8/390 |
17.89% 25/410 |
| 2018 | - - |
- - |
- - |
- - |
-5.54% 70/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 宝盈人工智能股票C VS. 东吴新产业精选股票A(580008) |